Drug Search Results
More Filters [+]

Aniracetam

Alternative Names: aniracetam
Latest Update: 2023-05-25
Latest Update Note: PubMed Publication

Product Description

Aniracetam is believed to be therapeutically useful for enhancing cognition, alleviating anxiety, and treating various neurodegenerative conditions. Physiologically, aniracetam enhances both glutamatergic neurotransmission and long-term potentiation. Aniracetam is a piracetam analog that has few reported side effects (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123976/)

Mechanisms of Action: AMPA Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Colombia | Egypt | Greece | Italy

Approved Indications: None

Known Adverse Events: None

Company: Longhua Hospital of Shanghai University of Traditional Chinese Medicine
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Aniracetam

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2000037418

N/A

Not yet recruiting

Unknown

2022-09-30

Recent News Events